Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis

被引:72
作者
Zhang, Li [1 ]
Wu, Guoqin [1 ]
Gao, Di [1 ]
Liu, Guijian [2 ]
Pan, Lin [1 ]
Ni, Liyan [3 ]
Li, Zheng [4 ]
Wang, Qiang [1 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Dept Dermatol, Shanghai 200433, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Key Lab Viral Heart Dis,Minist Publ Hlth, Shanghai 200433, Peoples R China
[3] Shanghai Skin Dis Hosp, Dept Dermatol, Shanghai, Peoples R China
[4] Fudan Univ, Zhongshan Hosp, Dept Biomed Res Ctr, Shanghai 200433, Peoples R China
来源
PLOS ONE | 2016年 / 11卷 / 05期
关键词
CLINICALLY AMYOPATHIC DERMATOMYOSITIS; IDIOPATHIC INFLAMMATORY MYOPATHIES; CATHEPSIN-B INHIBITOR; GENE; 5; PREDICTIVE FACTORS; JAPANESE PATIENTS; SHORT-TERM; MYOSITIS; ANTIBODY; ANTI-JO-1;
D O I
10.1371/journal.pone.0155381
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives Interstitial lung disease (ILD) is an extramuscular manifestation that results in increased morbidity and mortality from polymyositis (PM) and dermatomyositis (DM). The aim of this study was to systematically evaluate risk factors associated with the development of ILD in PM/DM. Methods Observational studies were identified from searching PubMed, Medline, Embase, and the Cochrane Library. Pooled odds ratios (ORs) or standardized mean differences (SMDs) and corresponding 95% confidence intervals (CIs) were obtained for the relationships between risk factors and ILD in PM/DM using either fixed-or random-effects models, whichever were appropriate. Heterogeneity tests, sensitivity analyses, and publication bias assessments were also performed. Results Twenty-three studies were selected for a meta-analysis that included 834 patients and 1245 control subjects. Risk factors that may have increased the risk of developing ILD in PM/DM patients included older age at diagnosis (SMD, 0.35; 95% CI, 0.18-0.52; P < 0.0001), arthritis/arthralgia (OR, 3.17; 95% CI, 1.99-5.04; P < 0.00001), fever (OR, 2.31; 95% CI, 1.42-3.76; P = 0.0007), presence of anti-Jo-1 antibodies (OR, 3.34; 95% CI, 2.165.16; P < 0.00001), elevated erythrocyte sedimentation rate (ESR; SMD, 0.48; 95% CI, 0.32-0.64; P < 0.00001), presence of anti-MDA5 antibodies (OR, 18.26; 95% CI, 9.66-34.51; P < 0.00001), and elevated C-reactive protein level (CRP; OR, 3.50; 95% CI, 1.48-8.28; P = 0.004). Meanwhile, malignancy (OR, 0.36; 95% CI, 0.18-0.72; P = 0.004) reduced the risk of developing ILD in PM/DM patients. Conclusion Our meta-analysis results suggest that the association between PM/DM and ILD may be due to such risk factors as older age at diagnosis, arthritis/arthralgia, fever, presence of anti-Jo-1 antibodies, elevated ESR, presence of anti-MDA5 antibodies, and elevated CRP level, while malignancy was associated with a reduced risk of developing ILD. Thus, these variables may be used to guide screening processes for ILD in patients with PM/DM.
引用
收藏
页数:15
相关论文
共 50 条
[21]   Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study [J].
Ji Su-yun ;
Zeng Fan-qin ;
Guo Qing ;
Tan Guo-zhen ;
Tang Hong-feng ;
Luo Yi-jin ;
Tang Zeng-qi ;
Han Yan-fang .
CHINESE MEDICAL JOURNAL, 2010, 123 (05) :517-522
[22]   A clinical analysis of prognostic factors for dermatomyositis-associated interstitial lung disease [J].
Zhang, Ti ;
Zhang, Ju ;
Liu, Xin ;
Zhang, Lanling ;
Zhao, Dongbao ;
Wu, Xin ;
Xu, Huji .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (06) :5903-5911
[23]   Comprehensive assessment of myositis-specific autoantibodies in polymyositis/dermatomyositis-associated interstitial lung disease [J].
Hozumi, Hironao ;
Fujisawa, Tomoyuki ;
Nakashima, Ran ;
Johkoh, Takeshi ;
Sumikawa, Hiromitsu ;
Murakami, Akihiro ;
Enomoto, Noriyuki ;
Inui, Naoki ;
Nakamura, Yutaro ;
Hosono, Yuji ;
Imura, Yoshitaka ;
Mimori, Tsuneyo ;
Suda, Takafumi .
RESPIRATORY MEDICINE, 2016, 121 :91-99
[24]   A Systematic Review and Metaanalysis of Predictors of Mortality in Idiopathic Inflammatory Myopathy-Associated Interstitial Lung Disease [J].
Hannah, Jennifer R. ;
Law, Huiyi E. ;
Gordon, Tanya ;
Rooney, Michael ;
Buazon, April ;
Adas, Maryam ;
Nagra, Deepak ;
Stovin, Christopher ;
Galloway, James ;
Gordon, Patrick A. .
JOURNAL OF RHEUMATOLOGY, 2023, 50 (03) :373-383
[25]   Serum ferritin as a significant biomarker for patients with idiopathic inflammatory myopathy-associated interstitial lung disease: A systematic review and meta-analysis [J].
He, Xing ;
Ji, Jiaqi ;
Chen, Xixi ;
Luo, Zeli ;
Fang, Siyu ;
Yan, Haiying ;
Guo, Lu .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 64
[26]   HMGB1 May Be a Biomarker for Predicting the Outcome in Patients with Polymyositis/Dermatomyositis with Interstitial Lung Disease [J].
Shu, Xiaoming ;
Peng, Qinglin ;
Lu, Xin ;
Wang, Guochun .
PLOS ONE, 2016, 11 (08)
[27]   Clinical analysis and outcome of interstitial lung disease complicated with juvenile dermatomyositis and juvenile polymyositis [J].
Sato, Satoshi ;
Uejima, Yoji ;
Nanbu, Meika ;
Suganuma, Eisuke ;
Takano, Tadamasa ;
Tanaka, Risa ;
Kabuki, Tomoyuki ;
Oguma, Eiji ;
Oh-Ishi, Tsutomu ;
Kawano, Yutaka .
MODERN RHEUMATOLOGY, 2017, 27 (04) :652-656
[28]   The therapeutic efficacy and safety of intravenous immunoglobulin in dermatomyositis and polymyositis: A systematic review and meta-analysis [J].
Xiong, Anji ;
Qiang, Yiying ;
Cao, Yuzi ;
Shuai, Yu ;
Chen, Huini ;
Xiang, Qilang ;
Hu, Ziyi ;
Song, Zhuoyao ;
Zhou, Shifeng ;
Zhang, Yan ;
Cui, Hongxu ;
Wang, Ye ;
Luo, Jie ;
Shuai, Shiquan ;
Yang, Yuan .
MODERN RHEUMATOLOGY, 2023, 33 (03) :533-542
[29]   Exploration of pathomechanism using comprehensive analysis of serum cytokines in polymyositis/dermatomyositis-interstitial lung disease [J].
Matsuda, Shogo ;
Kotani, Takuya ;
Ishida, Takaaki ;
Fukui, Keisuke ;
Fujiki, Youhei ;
Suzuka, Takayasu ;
Nagai, Koji ;
Hata, Kenichiro ;
Shoda, Takeshi ;
Isoda, Kentaro ;
Ito, Yuri ;
Makino, Shigeki ;
Takeuchi, Tohru ;
Arawaka, Shigeki .
RHEUMATOLOGY, 2020, 59 (02) :310-318
[30]   Prevalence and risk factors of systemic sclerosis-associated interstitial lung disease in East Asia: A systematic review and meta-analysis [J].
Qiu, Meihua ;
Nian, Xueyuan ;
Pang, Lingling ;
Yu, Pengfei ;
Zou, Shenchun .
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2021, 24 (12) :1449-1459